Merit Medical Systems acquired BioSphere Medical for approximately $96M in an all-cash transaction ($4.38 per share), gaining embolotherapy/embolic microsphere products for the treatment of uterine fibroids and hypervascular tumors.
Did it work? Outcome assessment
Merit Medical / BioSphere Medical: Achieved Stated Rationale (Score: 65/100)